• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立可靠的铜-64生产工艺:从靶材镀覆到分子特异性肿瘤微PET成像。

Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.

作者信息

Xie Qinghua, Zhu Hua, Wang Feng, Meng Xiangxi, Ren Qiushi, Xia Chuanqin, Yang Zhi

机构信息

College of Chemistry, Sichuan University, Chengdu 610064, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China.

出版信息

Molecules. 2017 Apr 17;22(4):641. doi: 10.3390/molecules22040641.

DOI:10.3390/molecules22040641
PMID:28420176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6154658/
Abstract

Copper-64 is a useful radioisotope for positron emission tomography (PET). Due to the wide range of applications, the demand of Cu with low metallic impurities is increasing. Here we report a simple method for the efficient production of high specific activity Cu using a cyclotron for biomedical application. We designed new equipment based on the plating of enriched Ni as the target, and used automated ion exchange chromatography to purify copper-64 efficiently after irradiation and dissolution of the target in good radiochemical and chemical yield and purity. The Cu radionuclide produced using 99.32% enriched Ni with a density of 61.4 ± 5.0 mg/cm², reaching a total radioactivity greater than 200 mCi, with specific activity up to 5.6 GBq/μmoL. It was further incorporated into modified monoclonal antibody DOTA-rituximab to synthesize Cu-DOTA-rituximab, which was used successfully for micro-PET imaging.

摘要

铜-64是一种用于正电子发射断层扫描(PET)的有用放射性同位素。由于应用范围广泛,对低金属杂质铜的需求正在增加。在此,我们报告一种使用回旋加速器高效生产高比活度铜的简单方法,用于生物医学应用。我们基于富集镍的电镀设计了新设备作为靶材,并在靶材辐照和溶解后,使用自动离子交换色谱法高效纯化铜-64,获得了良好的放射化学产率、化学产率和纯度。使用密度为61.4±5.0mg/cm²的99.32%富集镍生产的铜放射性核素,总放射性大于200mCi,比活度高达5.6GBq/μmoL。它进一步被掺入修饰的单克隆抗体DOTA-利妥昔单抗中,合成了铜-DOTA-利妥昔单抗,并成功用于微型PET成像。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/ed3556e17826/molecules-22-00641-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/b39019514d4a/molecules-22-00641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/3e9b13a9a4e6/molecules-22-00641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/ba70e1db886f/molecules-22-00641-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/88a0a0189820/molecules-22-00641-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/8714cc4809c2/molecules-22-00641-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/0b958809405d/molecules-22-00641-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/ed3556e17826/molecules-22-00641-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/b39019514d4a/molecules-22-00641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/3e9b13a9a4e6/molecules-22-00641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/ba70e1db886f/molecules-22-00641-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/88a0a0189820/molecules-22-00641-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/8714cc4809c2/molecules-22-00641-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/0b958809405d/molecules-22-00641-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/6154658/ed3556e17826/molecules-22-00641-g007.jpg

相似文献

1
Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.建立可靠的铜-64生产工艺:从靶材镀覆到分子特异性肿瘤微PET成像。
Molecules. 2017 Apr 17;22(4):641. doi: 10.3390/molecules22040641.
2
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron.使用12兆电子伏特回旋加速器生产治疗剂量的(64)铜。
Nucl Med Biol. 2003 Jul;30(5):535-9. doi: 10.1016/s0969-8051(03)00024-6.
3
Reactor produced [Cu]CuCl as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic.反应堆生产 [Cu]CuCl 作为癌症成像的 PET 放射性药物:从放射化学实验室到核医学临床。
Ann Nucl Med. 2020 Dec;34(12):899-910. doi: 10.1007/s12149-020-01522-2. Epub 2020 Oct 13.
4
Implementation of a new separation method to produce qualitatively improved Cu.实施一种新的分离方法以生产质量得到改善的铜。
J Labelled Comp Radiopharm. 2019 Jun 30;62(8):460-470. doi: 10.1002/jlcr.3730.
5
A simple and robust method for radiochemical separation of no-carrier-added Cu produced in a research reactor for radiopharmaceutical preparation.一种用于放射性药物制备的研究堆中无载体添加 Cu 的放射化学分离的简单而稳健的方法。
Appl Radiat Isot. 2020 Nov;165:109341. doi: 10.1016/j.apradiso.2020.109341. Epub 2020 Jul 24.
6
Cu production via the Zn(p,nα)Cu nuclear reaction: An untapped, cost-effective and high energy production route.通过 Zn(p,nα)Cu 核反应生产铜:一种未开发的、具有成本效益的高能生产途径。
Nucl Med Biol. 2024 Jan-Feb;128-129:108875. doi: 10.1016/j.nucmedbio.2024.108875. Epub 2024 Jan 6.
7
Efficient preparation of high-quality Cu for routine use.高效制备用于常规用途的高质量铜。
Nucl Med Biol. 2016 Nov;43(11):685-691. doi: 10.1016/j.nucmedbio.2016.07.007. Epub 2016 Jul 30.
8
A simple Cu-64 production and its application of Cu-64 ATSM.一种简单的铜-64生产方法及其铜-64-ATSM的应用。
Appl Radiat Isot. 2009 Jul-Aug;67(7-8):1190-4. doi: 10.1016/j.apradiso.2009.02.060. Epub 2009 Feb 23.
9
GMP-Automated Purification of Copper-61 Produced in Cyclotron Liquid Targets: Methodological Aspects.环流器液体靶中产生的 61Cu 的 GMP-自动化纯化:方法学方面。
Curr Radiopharm. 2021;14(4):420-428. doi: 10.2174/1874471013666201112141844.
10
Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.用于成像表达生长抑素受体肿瘤的(64)铜标记的DOTA-D-苯丙氨酸(1)-酪氨酸(3)-奥曲肽((64)铜-DOTA-TOC)的评估
Ann Nucl Med. 2009 Aug;23(6):559-67. doi: 10.1007/s12149-009-0274-0. Epub 2009 Jun 6.

引用本文的文献

1
Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets.神经降压素(8-13)和神经肽 N 放射性标记用固体或液体靶材生产的铜-64。
Molecules. 2024 Mar 20;29(6):1390. doi: 10.3390/molecules29061390.
2
Modifications in cellular viability, DNA damage and stress responses inflicted in cancer cells by copper-64 ions.铜-64离子对癌细胞造成的细胞活力、DNA损伤及应激反应的改变。
Front Med (Lausanne). 2023 Jun 21;10:1197846. doi: 10.3389/fmed.2023.1197846. eCollection 2023.
3
Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach.

本文引用的文献

1
Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies.前列腺腺癌的铜-PSMA-617 PET/CT成像:首例人体研究
Cancer Biother Radiopharm. 2016 Oct;31(8):277-286. doi: 10.1089/cbr.2015.1964. Epub 2016 Oct 7.
2
Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.通过遗传密码扩展合成用于放射免疫治疗的位点特异性放射性标记抗体。
Bioconjug Chem. 2016 Oct 19;27(10):2460-2468. doi: 10.1021/acs.bioconjchem.6b00412. Epub 2016 Sep 19.
3
Efficient preparation of high-quality Cu for routine use.
铜-64 标记抗体和纳米抗体:固相与液相靶标方法。
Molecules. 2023 Jun 9;28(12):4670. doi: 10.3390/molecules28124670.
4
Production Review of Accelerator-Based Medical Isotopes.基于加速器的医用同位素生产回顾。
Molecules. 2022 Aug 19;27(16):5294. doi: 10.3390/molecules27165294.
5
Highly Efficient Separation of Ultratrace Radioactive Copper Using a Flow Electrolysis Cell.使用流动电解池高效分离超痕量放射性铜。
ACS Omega. 2022 Apr 27;7(18):15779-15785. doi: 10.1021/acsomega.2c00828. eCollection 2022 May 10.
6
Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models.多模态成像技术利用曲妥珠单抗偶联有机纳米颗粒在患者来源的异种移植小鼠模型中有效监测肿瘤中的HER2表达。
Front Oncol. 2021 Nov 17;11:778728. doi: 10.3389/fonc.2021.778728. eCollection 2021.
7
Radionuclide Imaging of Fungal Infections and Correlation with the Host Defense Response.真菌感染的放射性核素成像及其与宿主防御反应的相关性。
J Fungi (Basel). 2021 May 22;7(6):407. doi: 10.3390/jof7060407.
8
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.用于肿瘤疾病成像的抗体免疫正电子发射断层显像/单光子发射计算机断层显像放射性药物的进展——最新情况
Cancers (Basel). 2020 Jul 11;12(7):1868. doi: 10.3390/cancers12071868.
9
Evaluation of Pan-SSTRs Targeted Radioligand [Cu]NOTA-PA1 Using Micro-PET Imaging in Xenografted Mice.使用微型PET成像在异种移植小鼠中评估泛生长抑素受体(Pan-SSTRs)靶向放射性配体[铜]NOTA-PA1
ACS Med Chem Lett. 2020 Feb 12;11(4):445-450. doi: 10.1021/acsmedchemlett.9b00544. eCollection 2020 Apr 9.
10
Porphyrins as ligands for copper: background and trends.卟啉作为铜的配体:背景与趋势
Medchemcomm. 2018 Aug 17;9(10):1577-1588. doi: 10.1039/c8md00263k. eCollection 2018 Oct 1.
高效制备用于常规用途的高质量铜。
Nucl Med Biol. 2016 Nov;43(11):685-691. doi: 10.1016/j.nucmedbio.2016.07.007. Epub 2016 Jul 30.
4
Pre-clinical Positron Emission Tomography Reconstruction Algorithm Effect on Cu-64 ATSM Lesion Hypoxia.临床前正电子发射断层扫描重建算法对Cu-64 ATSM病变缺氧的影响
Mol Imaging Radionucl Ther. 2016 Feb 5;25(1):19-25. doi: 10.4274/mirt.18189.
5
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients.64Cu-DOTATATE正电子发射断层显像术用于神经内分泌肿瘤:112例患者中与111In-DTPA-奥曲肽的前瞻性直接比较
J Nucl Med. 2015 Jun;56(6):847-54. doi: 10.2967/jnumed.115.156539. Epub 2015 May 7.
6
(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients.(64)Cu-DOTA-曲妥珠单抗PET成像与HER2阳性乳腺癌患者脑转移灶的HER2特异性
EJNMMI Res. 2015 Mar 12;5:8. doi: 10.1186/s13550-015-0082-6. eCollection 2015.
7
Validation of 64Cu-DOTA-rituximab injection preparation under good manufacturing practices: a PET tracer for imaging of B-cell non-Hodgkin lymphoma.64Cu-DOTA-利妥昔单抗注射液在药品生产质量管理规范下的验证:一种用于B细胞非霍奇金淋巴瘤成像的正电子发射断层显像(PET)示踪剂
Mol Imaging. 2015;14. doi: 10.2310/7290.2014.00055.
8
Automation of (64)Cu production at Turku PET Centre.图尔库正电子发射断层扫描中心的(64)铜生产自动化。
Appl Radiat Isot. 2014 Jul;89:74-8. doi: 10.1016/j.apradiso.2014.02.010. Epub 2014 Feb 21.
9
Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.心脏缺氧成像:64Cu-ATSM 的第二代类似物。
J Nucl Med. 2014 Mar;55(3):488-94. doi: 10.2967/jnumed.113.129015. Epub 2014 Jan 13.
10
Usefulness of 64Cu-ATSM in head and neck cancer: a preliminary prospective study.64Cu-ATSM 在头颈部癌症中的应用:一项初步前瞻性研究。
Clin Nucl Med. 2014 Jan;39(1):e59-63. doi: 10.1097/RLU.0b013e3182a756f0.